Ophthalmology and Visual Sciences, Dalhousie University Faculty of Medicine, Halifax, Nova Scotia, Canada
Ophthalmology and Visual Sciences, Dalhousie University Faculty of Medicine, Halifax, Nova Scotia, Canada.
BMJ Case Rep. 2024 Feb 14;17(2):e256860. doi: 10.1136/bcr-2023-256860.
We report a case of bilateral posterior ischaemic optic neuropathy, which followed vaccination with ChAdOx1 nCoV-19 for COVID-19 prophylaxis. A man in his early 60s was initially assessed for bilateral acute vision loss following 3 days of frontal headaches. The patient denied any other preceding visual concerns or symptoms of giant cell arteritis. The patient received his first dose of the ChAdOx1 nCoV-19 vaccination 10 days before the onset of his symptoms.At initial presentation, visual acuity was counting fingers bilaterally. Blood work found normal erythrocyte sedimentation rate (6 mm/hour) and C reactive protein (<5 mg/L) as well as a negative infectious and autoimmune serology. He was negative for COVID-19 with PCR testing. Diffusion-weighted MRI showed restricted diffusion along both optic nerves. After 5 months, the patient's visual acuity remained counting fingers bilaterally with pale optic nerves. Isolated bilateral posterior ischaemic optic neuropathy has not been reported in association with the ChAdOx1 nCoV-19 vaccine.
我们报告了一例双侧后部缺血性视神经病变病例,该病变发生在接种 ChAdOx1 nCoV-19 以预防 COVID-19 之后。一名 60 多岁的男子在出现额头痛 3 天后出现双侧急性视力丧失,最初接受评估。患者否认有任何先前的视觉问题或巨细胞动脉炎的症状。患者在症状出现前 10 天接受了第一剂 ChAdOx1 nCoV-19 疫苗接种。初次就诊时,双侧视力为指数计数。血液检查发现红细胞沉降率(6 毫米/小时)和 C 反应蛋白(<5 毫克/升)正常,感染和自身免疫血清学检查均为阴性。PCR 检测结果为 COVID-19 阴性。弥散加权 MRI 显示双侧视神经弥散受限。5 个月后,患者的双侧视力仍为指数计数,视神经苍白。尚未有报道称 ChAdOx1 nCoV-19 疫苗与孤立性双侧后部缺血性视神经病变有关。